Rixathon 500 mg/50 ml, Konzentrat zur Herstellung einer Infusionslösung

7680664350036 CH-66435 Konzentrat

Associated product:

RIXATHON conc perf 500 mg/50ml amp 50 ml
Rixathon 500 mg/50 ml, Konzentrat zur Herstellung einer Infusionslösung
Rixathon 500 mg/50 ml, Konzentrat zur Herstellung einer Infusionslösung
Rixathon 500 mg/50 ml, Konzentrat zur Herstellung einer Infusionslösung
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Konzentrat
Galenic group
Tinkturen/Desinfektion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
15/10/2024
Summary of Product Characteristics
Français
15/10/2024
Summary of Product Characteristics
Italien
15/10/2024

Detailed composition

Substance Quantity Type Category
(N/A)
500.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 1159.80
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/09/2018

Authorization holder

Sandoz Pharmaceuticals AG

6343 Risch

Authorization information

Swissmedic authorization number
66435
Drug name
Rixathon, Konzentrat zur Herstellung einer Infusionslösung
Galenic form
KOPA
ATC Code
L01FA01
Authorization status
Z
Dispensing category
A
First authorization
03/07/2018
Authorization expiration date
31/12/9999
IT Number
07.16.1.
Domain
Human medicine
Field of application
Non-Hodgkin-Lymphom, Rheumatoide Arthritis, ANCA-assoziierte Vasculitis

Package details

Description (FR)
RIXATHON conc perf 500 mg/50ml amp 50 ml
Description (DE)
RIXATHON Inf Konz 500 mg/50ml Amp 50 ml
Market launch
03/07/2018
Narcotic (BTM)
No

Other package sizes (3)

RIXATHON conc perf 100 mg/10ml 2 amp 10 ml
2 DUR
GTIN: 7680664350012
View
None
3 DUR
GTIN: None
Not in V1
None
2 DUR
GTIN: None
Not in V1